大麻使用、肺癌及相关问题
大麻及其衍生物有数百年的娱乐和药用历史,全球有数百万常规使用者。越来越多证据支持大麻用于化疗所致恶心呕吐和疼痛管理,但研究受限于标准化剂量估计困难及无法准确评估大麻产品中化合物的生物活性。吸烟大麻尚未被证明是肺癌发生的危险因素,但数据受限于小型研究、自我报告误分类、重度大麻吸烟者数量少以及已知肺癌致病因素(如并行长期烟草使用)的风险混杂。
要点
- 大麻在化疗所致恶心呕吐和疼痛管理中有新兴治疗作用,但研究有限。
- 吸烟大麻与肺癌风险的关系尚未证实,现有数据受多种局限。
- 大麻及其生物有效衍生物需要额外研究,理想为对照试验。
核心结论
- 大麻在化疗所致恶心呕吐和疼痛管理中有新兴治疗作用,但研究受限于剂量标准化和生物活性评估困难。
- 吸烟大麻尚未被证明是肺癌发生的危险因素,但现有数据受小型研究、自我报告误分类、重度吸烟者数量少和烟草使用混杂的限制。
- 大麻及其生物有效衍生物需要额外研究,理想为控制并记录大麻二酚和delta-9-四氢大麻酚强度及使用的对照试验。
研究设计与样本
- 原文为综述,未报告系统检索范围。
- 未报告样本量。
主要发现
- 大麻具有神经精神效应如抗焦虑和欣快感,反映其娱乐性使用。
- 大麻在慢性病和作为癌症治疗辅助手段方面有新兴治疗作用。
- 吸烟大麻与肺癌风险的关系尚未证实,数据受小型研究、自我报告误分类、重度大麻吸烟者数量少和已知肺癌致病因素混杂的限制。
临床怎么用
- 大麻可用于化疗所致恶心呕吐和疼痛管理,但需注意研究局限性。
- 吸烟大麻与肺癌风险的关系尚未证实,临床评估时应考虑烟草使用等混杂因素。
- 大麻及其衍生物的使用需要更多对照试验,控制并记录大麻二酚和delta-9-四氢大麻酚的强度和使用。
局限性
- 研究受限于标准化剂量估计困难。
- 无法准确评估大麻和衍生产品中化合物的生物活性。
- 吸烟大麻与肺癌风险的数据受小型研究、自我报告误分类、重度大麻吸烟者数量少和烟草使用混杂的限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The cannabis plant and its derivatives have been exploited for centuries for recreational and medicinal purposes, with millions of regular users around the world. The recreational use of cannabis is reflective of its neuropsychiatric effects, such as anxiolysis and euphoria. However, cannabis appears to have an emerging therapeutic role, especially in chronic disease and as an adjunct to cancer treatment. Increasing evidence supports cannabis in the management of chemotherapy-induced nausea and vomiting (CINV) and for pain management; however, studies are limited, particularly by difficulties associated with standardized dosing estimates and inability to accurately assess biologic activities of compounds in cannabis and derivative products. Smoking cannabis has not been proved to be a risk factor in the development of lung cancer, but the data are limited by small studies, misclassification due to self-reporting of use, small numbers of heavy cannabis smokers, and confounding of the risk associated with known causative agents for lung cancer (such as parallel chronic tobacco use). Cannabis and its biologically effective derivatives warrant additional research, ideally, controlled trials in which the cannabidiol and the delta-9-tetrahydrocabinol strength and use are controlled and documented.
引用
- Jett J, Stone E, Warren G, et al. Cannabis Use, Lung Cancer, and Related Issues. J Thorac Oncol. 2018. PMID: 29374567. doi:10.1016/j.jtho.2017.12.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。